Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Clinical characteristics -
--->News
[-]The Project
--->Sponsor
--->[-]Executive Committee
--->Arnesen
--->Blumenstein
--->Burgunder
--->Craufurd
--->Humbert
--->Jones
--->Kremer
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Public Documents
--->[-]Writing Committee Strategic ...
--->Dates
--->[-]Scientific and Bioethics Advis...
--->Becanovic
--->Busse
--->Frontali
--->Giorgini
--->Holmans
--->Mariotti
--->Norremolle
--->Reetz
--->Rickards
--->Saft
--->van Duijn
--->Valenza
--->Verellen
--->Public Documents
--->Central Coordination
--->Language Coordination
--->Fellowship Programme
--->[+]Constitution
--->[+]Voting/Nomination
--->[+]Members
[-]Locations
--->[+]Austria
--->[+]Belgium
--->[+]Czech Republic
--->[-]Denmark
--->[+]Coordination
--->HD Associations
--->Aarhus
--->Copenhagen
--->Odense
--->[+]Finland
--->[+]France
--->[+]Germany
--->[+]Ireland
--->[-]Italy
--->Coordination
--->HD Associations
--->Bari
--->Bologna
--->Brescia
--->Cagliari
--->Florence
--->Genoa
--->Milan
--->Napels
--->Pisa
--->Pozzilli
--->Rome
--->Rome-LIRH
--->Rome-Sant'Andrea
--->[+]Netherlands
--->[+]Norway
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[+]Spain
--->[+]Sweden
--->[+]Switzerland
--->[+]U.K.
--->[-]Outside Europe
--->[+]Seoul
--->[+]Singapore
--->Sydney
[-]Working Groups
--->[-]Advanced HD
--->Dates
--->[+]Meetings
--->[-]Behavioural Phenotype
--->Dates
--->[+]Meetings
--->[+]Psycho appr. & interv. Sub...
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[-]Brain and Tissue Banking
--->[+]Dates
--->[+]Meetings
--->[-]Cognitive Phenotype
--->[+]Dates
--->[+]Meetings
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[-]Genetic Modifiers
--->[+]Dates
--->[+]Meetings
--->[-]Health Economics
--->Dates
--->[+]Meetings
--->[+]Imaging
--->[-]Juvenile HD
--->Dates
--->[-]Motor Phenotype
--->[+]Dates
--->[+]Meetings
--->[-]Neuroprotective Therapy
--->[+]Dates
--->[+]Meetings
--->[-]Physiotherapy
--->Dates
--->[+]Meetings
--->[-]Quality of Life
--->[+]Dates
--->[+]Meetings
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[-]Symptomatic Research
--->[+]Dates
--->[+]Meetings
--->[+]Young Adults
[-]Events
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Communication
--->Contact Form
--->Chat Rooms
--->Mailinglists - public
--->Newsletter
--->Job Offers
datedescriptionsizeauthor document 
03.08.26Prospective diagnosis of Huntington Disease: prognostic indicators and directions for future study32 kBanonymousapplication/mswordh01-prospective-diagnosis 
03.08.26Progress report for the MODEL-HD project (follow up on EHDN announcement)32 kBanonymousapplication/mswordh02-progress-report-model-hd 
03.08.26Rate of progression is associated with age of disease onset for all HD32 kBanonymousapplication/mswordh03-rate-of-progression 
03.08.26Prognostic factors for the speed of progression of HD. Results of a re-evaluation of the Riluzole study32 kBanonymousapplication/mswordh04-prognostic-factors-speed-of-progre... 

Folder contains 4 documents.
about us | privacy statement | disclaimer | terms of use